Myovant Sciences Ltd. Stock
Equities
MYOV
BMG637AM1024
Biotechnology & Medical Research
Managers | Title | Age | Since |
---|---|---|---|
David C. Marek
CEO | Chief Executive Officer | 59 | 21-01-03 |
Adele Gulfo
BRD | Director/Board Member | 61 | 19-12-26 |
Marianne Romeo
PRN | Corporate Officer/Principal | 56 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Adele Gulfo
BRD | Director/Board Member | 61 | 19-12-26 |
David C. Marek
CEO | Chief Executive Officer | 59 | 21-01-03 |
Director/Board Member | 59 | 22-10-21 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.11% | 0 M€ | 0.00% | - | |
0.08% | 0 M€ | 0.00% | - |
1st Jan change | Capi. | |
---|---|---|
+1.12% | 42.59B | |
+6.77% | 40.65B | |
+46.73% | 40.57B | |
-11.96% | 26.77B | |
+6.01% | 24.81B | |
-24.92% | 18.17B | |
-3.63% | 11.7B | |
+27.16% | 12.05B | |
+7.30% | 11.1B |